Missouri will get almost $1 million in drug company settlement
The state of Missouri will receive nearly $1 million from a nationwide settlement over poorly manufactured drugs.
A spokeswoman for Attorney General Chris Koster says the state will return the money to a fund that funds consumer protections lawsuits.
Thirty-seven states and the District of Columbia joined the suit, which alleges that pharmaceutical giant GlaxoSmithKline and a Puerto Rican company, SB Pharmco, failed to properly manufacture several drugs at a plant in Puerto Rico. The drugs included one that helped cancer patients battle chemotherapy-related nausea, an antibiotic ointment, a form of the antidepressant drug Paxil, and a drug for Type II diabetes.
GSK and SB Pharmco will pay the states and D.C. a total of $40.75 million. The factory closed in 2008, and the drug batches covered by this suit have been recalled for years.
In a statement, GSK said it did not admit to wrongdoing in this latest settlement. The same two companies in 2010 agreed to pay $750 million in fines over the same facility.